These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26216968)

  • 41. Construction of human nonimmune library and selection of scFvs against IL-33.
    Yuan Q; Huang L; Wang X; Wu Y; Gao Y; Li C; Nian S
    Appl Biochem Biotechnol; 2012 Jun; 167(3):498-509. PubMed ID: 22562552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of single chain variable fragment (scFv) antibodies against surface proteins of 'Ca. Liberibacter asiaticus'.
    Yuan Q; Jordan R; Brlansky RH; Minenkova O; Hartung J
    J Microbiol Methods; 2016 Mar; 122():1-7. PubMed ID: 26744234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of a human CD8+ T lymphocyte neo-epitope created by a ras codon 12 mutation which is restricted by the HLA-A2 allele.
    Bergmann-Leitner ES; Kantor JA; Shupert WL; Schlom J; Abrams SI
    Cell Immunol; 1998 Aug; 187(2):103-16. PubMed ID: 9732698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA.
    Gedde-Dahl T; Spurkland A; Fossum B; Wittinghofer A; Thorsby E; Gaudernack G
    Eur J Immunol; 1994 Feb; 24(2):410-4. PubMed ID: 7507844
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone.
    Saruhan-Direskeneli G; Weber F; Meinl E; Pette M; Giegerich G; Hinkkanen A; Epplen JT; Hohlfeld R; Wekerle H
    Eur J Immunol; 1993 Feb; 23(2):530-6. PubMed ID: 7679649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolation and characterization of antibodies against three consecutive Tn-antigen clusters from a phage library displaying human single-chain variable fragments.
    Sakai K; Yuasa N; Tsukamoto K; Takasaki-Matsumoto A; Yajima Y; Sato R; Kawakami H; Mizuno M; Takayanagi A; Shimizu N; Nakata M; Fujita-Yamaguchi Y
    J Biochem; 2010 Jun; 147(6):809-17. PubMed ID: 20147453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay.
    Stuber G; Leder GH; Storkus WT; Lotze MT; Modrow S; Székely L; Wolf H; Klein E; Kärre K; Klein G
    Eur J Immunol; 1994 Mar; 24(3):765-8. PubMed ID: 8125143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides.
    Geluk A; Van Meijgaarden KE; Janson AA; Drijfhout JW; Meloen RH; De Vries RR; Ottenhoff TH
    J Immunol; 1992 Nov; 149(9):2864-71. PubMed ID: 1383331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of T cell epitopes restricted by HLA-DP9 in streptococcal M12 protein.
    Dong RP; Kamikawaji N; Toida N; Fujita Y; Kimura A; Sasazuki T
    J Immunol; 1995 May; 154(9):4536-45. PubMed ID: 7536773
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.
    Rossant CJ; Carroll D; Huang L; Elvin J; Neal F; Walker E; Benschop JJ; Kim EE; Barry ST; Vaughan TJ
    MAbs; 2014; 6(6):1425-38. PubMed ID: 25484064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mapping and ranking of potential cytotoxic T epitopes in the p53 protein: effect of mutations and polymorphism on peptide binding to purified and refolded HLA molecules.
    Gnjatic S; Bressac-de Paillerets B; Guillet JG; Choppin J
    Eur J Immunol; 1995 Jun; 25(6):1638-42. PubMed ID: 7542198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The soluble expression and identification of single-chain fragment V antibodies against SSA antigen epitopes from the pHEN2 phagemid library].
    Li HB; Zhang X; Tang FL; Zhang FC
    Zhonghua Nei Ke Za Zhi; 2010 Jul; 49(7):614-7. PubMed ID: 20979776
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification and characterization of HIV-1 epitopes presented by HLA-A*2603: comparison between HIV-1 epitopes presented by A*2601 and A*2603.
    Kawashima Y; Satoh M; Oka S; Takiguchi M
    Hum Immunol; 2005 Nov; 66(11):1155-66. PubMed ID: 16571416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the fine specificity of peptide antibodies to HLA-DQ beta-chain molecules.
    Petersen JS; Atar D; Karlsen A; Kofod H; Dyrberg T
    Biomed Biochim Acta; 1990; 49(12):1223-32. PubMed ID: 1711320
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Broadening the repertoire of melanoma-associated T-cell epitopes.
    Frøsig TM; Lyngaa R; Met Ö; Larsen SK; Donia M; Svane IM; Thor Straten P; Hadrup SR
    Cancer Immunol Immunother; 2015 May; 64(5):609-20. PubMed ID: 25854582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anti-HLA-E mAb 3D12 mimics MEM-E/02 in binding to HLA-B and HLA-C alleles: Web-tools validate the immunogenic epitopes of HLA-E recognized by the antibodies.
    Ravindranath MH; Pham T; El-Awar N; Kaneku H; Terasaki PI
    Mol Immunol; 2011 Jan; 48(4):423-30. PubMed ID: 21145594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope density.
    Stranzl T; Larsen MV; Lund O; Nielsen M; Brunak S
    PLoS One; 2012; 7(9):e38670. PubMed ID: 23049726
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation, selection and modification of anti-cardiac troponin I antibodies with high specificity and affinity.
    Ma H; Cassedy A; Ó'Fágáin C; O'Kennedy R
    J Immunol Methods; 2022 Jan; 500():113183. PubMed ID: 34774542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrophobic interactions dominate the recognition of a KRAS G12V neoantigen.
    Wright KM; DiNapoli SR; Miller MS; Aitana Azurmendi P; Zhao X; Yu Z; Chakrabarti M; Shi W; Douglass J; Hwang MS; Hsiue EH; Mog BJ; Pearlman AH; Paul S; Konig MF; Pardoll DM; Bettegowda C; Papadopoulos N; Kinzler KW; Vogelstein B; Zhou S; Gabelli SB
    Nat Commun; 2023 Aug; 14(1):5063. PubMed ID: 37604828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.